David G. Wolinsky MD FACC FASNC MASNC
Heart Failure & Transplantation, Nuclear Cardiology, Preventive Cardiology, Exercise Physiology and Cardiac Rehabilitation
Effective Oct 2011 I will be at Cleveland Clinic , Weston Florida
Join to view full profile
2950 Cleveland Clinic BlvdWeston, FL 33331
Phone+1 954-659-5320
Dr. Wolinsky is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Section Head Nuclear Cardiology Cleveland Clinic Florida
Direrctor , Cardiac Amyloid center Cleveland Clinic Florida
Past President, American Society of Nuclear Cardiology
Chair, Health Policy Committee , American Society of Nuclear Cardiology
Education & Training
Icahn School of Medicine at Mount Sinai/Morningside/BronxCareFellowship, Cardiovascular Disease, 1981 - 1983- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1978 - 1981
Columbia University Vagelos College of Physicians and SurgeonsClass of 1978
Columbia CollegeB.A., Biochemistry, 1970 - 1974
Certifications & Licensure
FL State Medical License 2011 - 2027
NY State Medical License 1980 - 2018
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsComparative Insights on Inpatient Outcomes in Diastolic Heart Failure with and Without Amyloidosis: A Nationwide Propensity-Matched Analysis.Aravind Dilli Babu, Mirza Faris Ali Baig, David A Baran, Jerry Estep, David Wolinsky
Journal of Cardiovascular Development and Disease. 2025-05-16 - 9 citationsTransthyretin cardiac amyloid: Broad heart failure phenotypic spectrum and implications for diagnosis.Mileydis Alonso, Radhika K Neicheril, Yosef Manla, Malcolm L McDonald, Alejandro Sanchez
ESC Heart Failure. 2024-12-01 - 6 citationsPredictors of developing renal dysfunction following diagnosis of transthyretin cardiac amyloidosis.Malcolm L McDonald, Yosef Manla, Alice Sonnino, Mileydis Alonso, Radhika K Neicheril
Clinical Cardiology. 2024-06-01
Journal Articles
- Hernandez MB, Ballesteros P, Schwartz R, Cadette M, Asher C, Novaro G, Wolinsky D, Shen M., JACC, 1/1/2012
- Hendel RC, Abbott BG, Bateman TM, Blankstein R, Calnon DA, Leppo JA ,MAddahi J, Schumaecker MM, Shaw LJ, Ward RP, Wolinsky DG., J Nucl Cardiol., 1/1/2011
- Wolinsky DG, Calnon DA, Hansen CL, Jaber WA, Lewin HC, Merlino D, Rosenblatt, JA, Sundarum S, Travin MI, Van Tosh A., J NUcl Cardiol, 1/1/2011
Press Mentions
Heart Disease Is the Leading Cause of Death in Women. So Where’s the Research?February 21st, 2017
Flurpiridaz Clinical Trial Results Will Be Announced at ASNC2022August 12th, 2022
How to Start a Cardiac PET-CT Imaging ProgramFebruary 19th, 2020
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
